April Update Affects Coverage for 23 Lab NCDs
- By Renee Dustman
- In Industry News
- May 21, 2018
- Comments Off on April Update Affects Coverage for 23 Lab NCDs

Twenty-three National Coverage Determinations (NCDs) for clinical diagnostic laboratory services have been updated to reflect the April 2018 quarterly release of the edit module for such services. ICD-10-CM codes in effect April 1 affect coverage for several common lab tests.
Note ICD-10-CM Code Changes in Lab NCDs
The following lab NCDs add/delete ICD-10-CM codes from the list of covered/denied diagnoses:
190.12 Urine Culture, Bacterial
190.13 Human Immunodeficiency Virus (HIV) Testing (Prognosis Including Monitoring)
190.14 Human Immunodeficiency Virus (HIV) Testing Diagnosis
190.15 Blood Counts
190.16 Partial Thromboplastin Time (PTT)
190.17 Prothrombin Time (PT)
190.18 Serum Iron Studies
190.19 Collagen Crosslinks, Any Method
190.20A Blood Glucose Testing
190.20B Blood Glucose Testing
190.21 Glycated Hemoglobin/Glycated Protein
190.22 Thyroid Testing
190.23A Lipids Testing
190.23B Lipids Testing
190.25 Alpha-fetoprotein
190.26 Carcinoembryonic Antigen
190.28 Tumor Antigen by Immunoassay CA 125
190.29 Tumor Antigen by Immunoassay CA 15-3/CA 27.29
190.30 Tumor Antigen by Immunoassay CA 19-9
190.31 Prostate Specific Antigen
190.32 Gamma Glutamyl Transferase
190.33 Hepatitis Panel/Acute Hepatitis Panel
190.34 Fecal Occult Blood Test
Non-covered ICD-10-CM Codes for All Lab NCDs
With the Oct. 1, 2017, update to the ICD-10-CM code set, several codes were added to Chapter 21: Factors Influencing Health Status and Contact with Health Services (Z00-Z99).
Specifically, codes Z36.0-Z36.9 were added “to account for encounters for antenatal screening for various issues (e.g., Z36.4 Encounter for antenatal screening for fetal growth retardation),” reported Amy C. Pritchett, BSHA, CPC, CPMA, CPC-I, CANPC, CASCC, CEDC, CRC, CDEO, CCS, ICDCT-CM/PCS, C-AHI, in the article “Look Ahead at ICD-10-CM in 2018” (Healthcare Business Monthly, December 2017). “There are also some note changes, so review this chapter carefully.”
ICD-10-CM Codes
Z36.0 | Encounter for antenatal screening for chromosomal anomalies |
Z36.1 | Encounter for antenatal screening for raised alphafetoprotein level |
Z36.2 | Encounter for other antenatal screening follow-up |
Z36.3 | Encounter for antenatal screening for malformations |
Z36.4 | Encounter for antenatal screening for fetal growth retardation |
Z36.5 | Encounter for antenatal screening for isoimmunization |
Z36.81 | Encounter for antenatal screening for hydrops fetalis |
Z36.82 | Encounter for antenatal screening for nuchal translucency |
Z36.83 | Encounter for fetal screening for congenital cardiac abnormalities |
Z36.84 | Encounter for antenatal screening for fetal lung maturity |
Z36.85 | Encounter for antenatal screening for Streptococcus B |
Z36.86 | Encounter for antenatal screening for cervical length |
Z36.87 | Encounter for antenatal screening for uncertain dates |
Z36.88 | Encounter for antenatal screening for fetal macrosomia |
Z36.89 | Encounter for other specified antenatal screening |
Z36.8A | Encounter for antenatal screening for other genetic defects |
Z36.9 | Encounter for antenatal screening, unspecified |
These codes are never covered by Medicare for a diagnostic lab testing service. If a code from this section is given as the reason for the test, the test may be billed to the Medicare beneficiary without billing Medicare first because the service is not covered by statute, in most instances because it is performed for screening purposes and is not within an exception. The beneficiary, however, does have a right to have the claim submitted to Medicare, upon request.
Update Your Code Lists
The Centers for Medicare & Medicaid Services (CMS) Change Request 10424 adds to the list of ICD-10-CM codes that are covered/noncovered for the following NCDs, effective April 1, 2018.
Note: The codes listed below are just those added for the April 2018 update. See the NCD for the complete list of covered/non-covered codes.
NCD 190.15
Non-covered:
T07.XXXA | Unspecified multiple injuries, initial encounter |
T07.XXXS | Unspecified multiple injuries, sequela |
T14.8XXS | Other injury of unspecified body region, sequela |
T14.90XA | Injury, unspecified, initial encounter |
T14.90XS | Injury, unspecified, sequela |
NCD 190.16
Covered:
E85.82 | Wild-type transthyretin-related (ATTR) amyloidosis |
E85.89 | Other amyloidosis |
K56.699 | Other intestinal obstruction unspecified as to partial versus complete obstruction |
NCD 190.17
Covered:
D47.09 | Other mast cell neoplasms of uncertain behavior |
E85.82 | Wild-type transthyretin-related (ATTR) amyloidosis |
E85.89 | Other amyloidosis |
K56.699 | Other intestinal obstruction unspecified as to partial versus complete obstruction |
K91.30 | Postprocedural intestinal obstruction, unspecified as to partial versus complete |
K91.31 | Postprocedural partial intestinal obstruction |
K91.32 | Postprocedural complete intestinal obstruction |
T14.8XXA | Other injury of unspecified body region, initial encounter |
T14.90XA | Injury, unspecified, initial encounter |
NCD 190.18
Covered:
A04.71 | Enterocolitis due to Clostridium difficile, recurrent |
A04.72 | Enterocolitis due to Clostridium difficile, not specified as recurrent |
D47.09 | Other mast cell neoplasms of uncertain behavior |
K56.699 | Other intestinal obstruction unspecified as to partial versus complete obstruction |
NCD 190.23
Covered:
E85.82 | Wild-type transthyretin-related (ATTR) amyloidosis |
E85.89 | Other amyloidosis |
NCD 190.32
Covered:
D47.09 | Other mast cell neoplasms of uncertain behavior | |
E85.82 | Wild-type transthyretin-related (ATTR) amyloidosis | |
E85.89 | Other amyloidosis | |
F13.11 | Sedative, hypnotic or anxiolytic abuse, in remission | |
F16.11 | Hallucinogen abuse, in remission | |
F18.11 | Inhalant abuse, in remission | |
F19.11 | Other psychoactive substance abuse, in remission | |
K56.50 | Intestinal adhesions [bands], unspecified as to partial versus complete obstruction | |
K56.51 | Intestinal adhesions [bands], with partial obstruction | |
K56.52 | Intestinal adhesions [bands] with complete obstruction | |
K56.600 | Partial intestinal obstruction, unspecified as to cause | |
K56.601 | Complete intestinal obstruction, unspecified as to cause | |
K56.609 | Unspecified intestinal obstruction, unspecified as to partial versus complete obstruction | |
K56.690 | Other partial intestinal obstruction | |
K56.691 | Other complete intestinal obstruction | |
K56.699 | Other intestinal obstruction unspecified as to partial versus complete obstruction |
NCD 190.34
Covered:
A04.71 | Enterocolitis due to Clostridium difficile, recurrent |
A04.72 | Enterocolitis due to Clostridium difficile, not specified as recurrent |
K56.699 | Other intestinal obstruction unspecified as to partial versus complete obstruction |
Know When to Code Diagnoses vs. Signs and Symptoms
On and after the implementation date for ICD-10-CM coding of Medicare billing claims, a claim for a clinical diagnostic laboratory service must include a valid ICD-10-CM diagnosis code. When a diagnosis has not been established by the physician, codes that describe symptoms and signs, as opposed to diagnoses, should be provided.
Source:
April 2018 ICD-10-CM quarterly update to Lab NCDs
https://www.cms.gov/Medicare/Coverage/CoverageGenInfo/LabNCDsICD10.html
- CMS Corrects Time Thresholds for Prolonged Services - March 14, 2023
- IDR Payment Determinations Resume Under No Surprises Act - March 3, 2023
- 7 Tips for Diagnostic Radiology Coding - March 1, 2023